Impaired hepatic granuloma formation in mice deficient in C-C chemokine receptor 2

被引:19
作者
Jinnouchi, K
Terasaki, Y
Fujiyama, S
Tomita, K
Kuziel, WA
Maeda, N
Takahashi, K
Takeya, M
机构
[1] Kumamoto Univ, Sch Med, Dept Pathol 2, Kumamoto 8620811, Japan
[2] Kumamoto Univ, Sch Med, Dept Internal Med 3, Kumamoto 8620811, Japan
[3] Univ Texas, Sect Mol Genet & Microbiol, Austin, TX 78712 USA
[4] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA
关键词
hepatic granuloma; CCR2; knockout mice; immunohistochemistry; giant cells;
D O I
10.1002/path.1362
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Granulomas are characterized histologically by a nodular collection of macrophages with occasional admixture of epithelioid cells, multinucleate giant cells, and other immunocompetent cells. Chemokines are considered to play an important role in the recruitment of these constituent cells of granulomas. The present study has examined the effect of a deficiency of C-C chemokine receptor-2 (CCR2) on hepatic granuloma formation induced by a single injection of Zymosan A. In CCR2+/+ mice, the number and the size of granulomas gradually increased until they reached peak values at 10 days after the injection. In contrast, both the number and the size of granulomas were smaller in CCR2-/- mice than in CCR2+/+ mice from days 5 to 21. They showed low peaks at day 5, after which the number and the size of the granulomas gradually decreased. Inummohistochemical analysis of the constituent granuloma cells using cell type-specific monoclonal antibodies revealed rapid accumulation of blood monocytes, with subsequent differentiation to macrophages, in CCR2+/+ mice during days 2-10. This process was greatly impaired in CCR2-/- mice and granulomas remained small. At all time points, the percentage of polymorphonuclear cells in granulomas was higher in CCR2-/- mice than in CCR2+/+ mice. Interestingly, multinucleate giant cells were frequently observed in granulomas in CCR2-/- mice, whereas they rarely appeared in CCR2+/+ mice. Profiles of liver cytokine RNA levels as well as serum cytokine levels revealed reduced expression of the Th1 cytokine IFN-gamma in CCR2-/- mice. These data clearly indicate that signalling through CCR2 has many effects on the normal growth and development of hepatic granulomas. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:406 / 416
页数:11
相关论文
共 50 条
  • [1] Inhibition of the chemokine (C-C motif) ligand 2/chemokine (C-C motif) receptor 2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis and lipoatrophy
    Yang, S. J.
    IglayReger, H. B.
    Kadouh, H. C.
    Bodary, P. F.
    DIABETOLOGIA, 2009, 52 (05) : 972 - 981
  • [2] C-C motif chemokine ligand 2/C-C receptor 2 is associated with glioma recurrence and poor survival
    Yang, Qiuan
    Zhang, Junpeng
    Zhang, Xin
    Miao, Lifeng
    Zhang, Wei
    Jiang, Zheng
    Zhou, Wei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (06)
  • [3] C-C motif chemokine ligand 2/C-C motif chemokine receptor 2 pathway as a therapeutic target and regulatory mechanism for spinal cord injury
    Wang, Xiangzi
    Niu, Xiaofei
    Wang, Yingkai
    Liu, Yang
    Yang, Cheng
    Chen, Xuyi
    Qi, Zhongquan
    NEURAL REGENERATION RESEARCH, 2025, 20 (08) : 2231 - 2244
  • [4] Investigational C-C chemokine receptor 2 antagonists for the treatment of autoimmune diseases
    Kalinowska, Alicja
    Losy, Jacek
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (09) : 1267 - 1279
  • [5] Chemokine (c-c motif) receptor 2 mediates mechanical and cold hypersensitivity in sickle cell disease mice
    Sadler, Katelyn E.
    Zappia, Katherine J.
    O'Hara, Crystal L.
    Langer, Sarah N.
    Weyer, Andy D.
    Hillery, Cheryl A.
    Stucky, Cheryl L.
    PAIN, 2018, 159 (08) : 1652 - 1663
  • [6] Potentials of C-C motif chemokine 2-C-C chemokine receptor type 2 blockers including propagermanium as anticancer agents
    Yumimoto, Kanae
    Sugiyama, Shigeaki
    Mimori, Koshi
    Nakayama, Keiichi I.
    CANCER SCIENCE, 2019, 110 (07) : 2090 - 2099
  • [7] Chemokine (C-C motif) receptor 2 mediates mast cell migration to abdominal aortic aneurysm lesions in mice
    Zhang, Jie
    Chen, Huimei
    Liu, Li
    Sun, Jiusong
    Shi, Michael A.
    Sukhova, Galina K.
    Shi, Guo-Ping
    CARDIOVASCULAR RESEARCH, 2012, 96 (03) : 543 - 551
  • [8] Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice
    You, Hanning
    Gao, Ting
    Raup-Konsavage, Wesley M.
    Cooper, Timothy K.
    Bronson, Sarah K.
    Reeves, W. Brian
    Awad, Alaa S.
    KIDNEY INTERNATIONAL, 2017, 91 (03) : 671 - 682
  • [9] C-C chemokine receptor 2 gene polymorphism in Japanese patients with multiple sclerosis
    Miyagishi, R
    Niino, M
    Fukazawa, T
    Yabe, I
    Kikuchi, S
    Tashiro, K
    JOURNAL OF NEUROIMMUNOLOGY, 2003, 145 (1-2) : 135 - 138
  • [10] Pharmacological Inhibition of C-C Chemokine Receptor 2 Decreases Macrophage Infiltration in the Aortic Root of the Human C-C Chemokine Receptor 2/Apolipoprotein E-/- Mouse: Magnetic Resonance Imaging Assessment
    Olzinski, Alan R.
    Turner, Gregory H.
    Bernard, Roberta E.
    Karr, Heather
    Cornejo, Carla A.
    Aravindhan, Karpagam
    Hoang, Bao
    Ringenberg, Michael A.
    Qin, Pu
    Goodman, Krista B.
    Willette, Robert N.
    Macphee, Colin H.
    Jucker, Beat M.
    Sehon, Clark A.
    Gough, Peter J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2010, 30 (02) : 253 - U240